Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19

Since December 2019, a novel type of coronavirus disease (COVID-19) in Wuhan led to an outbreak throughout China and the rest of the world. To date, there have been more than 1,260,000 COVID-19 patients, with a mortality rate of approximately 5.44%. Studies have shown that coagulation dysfunction is...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jing-Chun, Wang, Gang, Zhang, Wei, Zhang, Yang, Li, Wei-Qin, Zhou, Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Position article and Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167301/
https://www.ncbi.nlm.nih.gov/pubmed/32307014
http://dx.doi.org/10.1186/s40779-020-00247-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167301/
https://www.ncbi.nlm.nih.gov/pubmed/32307014
http://dx.doi.org/10.1186/s40779-020-00247-7

Ejemplares similares